claudin-19 Antibodies

Santa Cruz Biotechnology delivers a wide array of claudin-19 monoclonal antibodies for research focused on understanding this critical tight junction protein. claudin-19 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Claudin-19 is essential for maintaining the integrity of epithelial barriers and plays a significant role in regulating paracellular permeability. Expression of claudin-19 is particularly important in the kidney and retina, where it contributes to the formation of tight junctions crucial for proper function. Dysregulation of claudin-19 has been implicated in various diseases, including certain types of cancer and renal disorders, highlighting its importance in both health and disease. Research has shown that claudin-19 interacts with other tight junction proteins to form complex barriers that regulate ion selectivity and maintain cellular polarity. Understanding claudin-19's molecular mechanisms and signaling pathways can provide valuable insights into disease development and potential therapeutic strategies. Ongoing studies continue to reveal new functions and regulatory mechanisms of claudin-19 in different tissue types. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of claudin-19's role in health and disease.